Cel-Sci Corporation Insider Trading

CVM

⊜ Compare

Last 12 months

Insiders bought 867K on the open market and sold nothing.

Net open-market

+867K

5 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 25, 2026

Get an email when CVM's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 25	Geert R Kersten Chief Executive Officer	Bought	100,000	$1.38	138K	19%	Form 4
May 14	Geert R Kersten Chief Executive Officer	Bought	300,000	$1.20	360K	135%	Form 4
May 13	Geert R Kersten Chief Executive Officer	Bought	100,000	$1.19	119K	82%	Form 4
Jan 22	Geert R Kersten Chief Executive Officer	Bought	38,023	$5.26	200K	46%	Form 4
Dec 4, 2025	Geert R Kersten Chief Executive Officer	Bought	8,389	$5.96	50K	11%	Form 4
Jul 25, 2025	Robert Eugene Watson Director	Bought	2,919	$6.85	20K	359%	Form 4
Jul 25, 2025	Geert R Kersten Chief Executive Officer	Bought	29,197	$6.85	200K	67%	Form 4

Aug 25
Geert R Kersten
Chief Executive Officer · bought 100,000 at $1.38
138K
19% of stake
May 14
Geert R Kersten
Chief Executive Officer · bought 300,000 at $1.20
360K
135% of stake
May 13
Geert R Kersten
Chief Executive Officer · bought 100,000 at $1.19
119K
82% of stake
Jan 22
Geert R Kersten
Chief Executive Officer · bought 38,023 at $5.26
200K
46% of stake
Dec 4, 2025
Geert R Kersten
Chief Executive Officer · bought 8,389 at $5.96
50K
11% of stake
Jul 25, 2025
Robert Eugene Watson
Director · bought 2,919 at $6.85
20K
359% of stake
Jul 25, 2025
Geert R Kersten
Chief Executive Officer · bought 29,197 at $6.85
200K
67% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CVM, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CVM

CompareIntrinsic value

BCABBioAtla, Inc.

$2.00+0.00%0

ZIVOZivo Bioscience Inc.

$8.00+10.34%0

WINTWindtree Therapeutics Inc.

$0.00+0.00%10

ATYRAtyr Pharma Inc.

$6.18-6.79%10

ARMPArmata Pharmaceuticals Inc.

$3.14+1.62%30

VIVSVivoSim Labs, Inc.

$0.15+8.71%10

AIMAIM ImmunoTech Inc.

$0.16+0.63%15

INMBInmune Bio Inc.

$1.33+0.76%10

Spot a number that looks wrong? Check it in CVM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CVM

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.